Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denikitug Monotherapy and Combinations in Advanced MSS Colorectal Cancer
NCT07527858Phase 2Recruiting
- Sponsor
- Gilead Sciences
- Start
- May 2026
- Primary completion
- Dec 2028
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of denikitug in colorectal cancer (CRC), sponsored by Gilead Sciences. Started May 2026; status: recruiting.
02
Drugs
denikitug
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07527858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07527858.